{"name":"Solu Therapeutics, Inc","slug":"solu-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-23","type":"deal","source":"PR Newswire","summary":"Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and L","headline":"Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxNVm1LbnE5TEtYejhQNjZDYWRZZXhiSkZJNTNJRGlZX1h0X1lWdm1ORTlCVEk1U3E5N0IydkF1bnFuUTBaQnczRkpSWjBVYnRGQjRfTmluQlFwWldKUi1kaGR6XzdHWENzZ0dKN2piVXM4T2dqRmEzXzlvYXlBajVkdkRTSXVfV2JfQUlLVVdKWDNiV1AxT1BLYjBIX2xBVXQzNmpxNTBVY1lUYWZQcndKQU5FNVNtYmxsbXEtbF9ISEZCRjRsRmNBbzY2d19nX05wYklsOTZOWUVSMzdaa1MxSTlmMS1fZzhKUUgxUjhQdU15Tk5oVnRYWTBsdzdiUllybTlmS3paSTE2QWdsN2xkNi1SUDhoZUF5Rl80U3RIa0JneXMwLWlfUmMzSk10UWRDclRibnllem14cHRHZWRBRGRrTHh1U3NxZXlvYQ?oc=5","date":"2026-03-02","type":"pipeline","source":"globenewswire.com","summary":"Eton Pharmaceuticals Expands Rare Disease Portfolio Through - globenewswire.com","headline":"Eton Pharmaceuticals Expands Rare Disease Portfolio Through","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOYkp4R18tR0xkd1B4cmM0dU9PbEd0M250bkNkNjAtZ3BEaGdXTFIxdFU0TmJBN0lITTEyR2QtdE5hUnFqRWYzUWZzblJmVFBUdjk5d0dsQmlPRktZVzdxU1AwRnpKWDlfU3lONzIzaHVDR2dSZUpsY0MxYUdfb25KeFpTVlFlSXRQSDY1QVZLVzRkWHh1WmJQOXFCWUVablFyZG5tVUpmUmRpa1NUZFpDRHJ2RUpvUGhkR1BWakpkQ1o0czNuQWxBR0dXeHpXOTg4N0FfVXV4VnBsMkRNYjNJdEVNNW9pOW1JOWVVLXI2dC1nb3B3STZWNVZ3?oc=5","date":"2026-02-25","type":"regulatory","source":"globenewswire.com","summary":"Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution - globenewswire.com","headline":"Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxNZHlvcnZrZ3IwVW5fbGRCWUlMdGd4bjJHYWw0QVRfdnFiU19XS2NyNEZiTjdodlBGVk8xRFU4YlJwbUNpellBeWJZVW9TRE9pRkU3ZGJmYjJKZ3ZTMGxtVWtsdkFhakM4YmFMNWllTHhyZGdYcm9lU0dvalYzR1B0T0tnd3V0SWduQi03eDFUTm0zWjBsdHdmNGw0dU4zbUFqSFNtZUJaOXQ3Y1l1cGtZX2tBN2RUVThLR21CcDR5dUZ0Q2lFYWFGOU1XbmVjc0JoY3FId25XRzlsQ2FGSlBZYVdDb0JMVmFXYl84VDVic3hOVC03eUtzTkh0VndMc0pycTdCNGFUcC1RQlZnczJXRlR6U1V2aEE4UWUzWXV0Yk5KV2wxYW9CVXNNUWFQU1FWZGlxNnJyeWZLQ1pOdTNSWm9SaEE?oc=5","date":"2025-12-12","type":"pipeline","source":"Business Wire","summary":"STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome - Business Wire","headline":"STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxOWi1lSDdMNkR4S1FZNU9HTzNWRWRWaWVwcE1TcTRaR19Pc0dWQTZkVkVzWjRYOVY3UGpHei1tSG5VUkZyRWt2Q3huRzRGZHp3dUlSMU9zWGpvdHNERjFLZTc4c2ViZm5nVVJPQU5LYllnUnB1RUNGSkE1V0ZlQVNhWjhlNkQ1dHZNUGFRcTI2WkpCUnJ6eGljUU03MU5CcWpwQkpkQ2NJMEoyVVhTNmdSMUZXMTA5S2Y0cjI2Rzk2eHRFb1Q5Y2ZLOWFlN0xCM3M2RUI1UHdSaVZWMDBvT3lmZERGY1JzWjE2S2NCaEE2d1lTUzM0TklRWjZjZWlKSHIxMjVQNmJpQVoxZ0ZGYUVkcTZOVHlsUVFOZTIwbFpPZ25kcmE4OTBlTWZEVC10VTl1X2VLMjhfbXhURFNKT0VtVkpSYUthWnEySmpr?oc=5","date":"2025-12-02","type":"trial","source":"PR Newswire","summary":"Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting - PR Newswire","headline":"Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPcjQtMlo0bFRmX0ZIQUNtNXU2cG9BbFhnbWR0SnBXaHh0ZFN2TEFqSlJ6R1gxTHZvV3dEbFZaRFdkRW81aVR2LXZNOFprVW5XZ1doUXNORWI5Wld1cXJVallReWZZNU9xOU1yQ0RJRkd2MWdydEthSmVVRUd5WF91dXdrUG1INGo3SkJ3Wlpn?oc=5","date":"2025-11-27","type":"trial","source":"Yahoo Finance","summary":"Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation - Yahoo Finance","headline":"Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOaDB4c1ZSamZuSjA3U2FvcnVPX1JmOVY4LTVqZHZxeGN6aG5OQzFEdHc5U0s3b01ySlptbGNYaWd0VXVCRUJPR2xNU3VyTG5TQklKbUlsNDJicjBNbUlLTXVoN2RRMkVWSGhJaGFRZndtSHN2Y1M1RmZsbWpKN3lPY3Fsa18xZktkQjJRVnhzLWI?oc=5","date":"2025-11-07","type":"pipeline","source":"Yahoo Finance","summary":"Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program - Yahoo Finance","headline":"Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQSjlwdWJzNjZrY1h2MEEtNVlwSHpIYnVpeHVERHRBRV9OMHU0YVdueVo2ZzhpVjlQcjVjTDNOelYtN0Y1cFE1STZ6UkZMNDBUSGx2eXkyRjNsdGZTVXVWUTU4VWpyaDFuRmFuTHA5Q181QzNPWnZpNGIzNEZtVHp0VjZrQVhrOGtkNDdNV21hVDJVcmFpOE5obWdTd21qR09LeHNDaVYxVDJ2dDZNUEZBN1NrejhaV29Jb21VMEhmSnE?oc=5","date":"2025-09-18","type":"deal","source":"Biogen","summary":"Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates - Biogen","headline":"Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNQ0tVa2pCR1BtbjhUcld6anVwN3pxMkhmOGQ4QVhYeXplSVF2Z1liR0NrYjhScDZ6bkdFSnE0d09uQS1kcEVBclR0bmN0cG95YnplZW5feEx4MVkzaUp5NUhzWUljOFJ1SDJVVkwwM1NuYWdaelc4dlZPajZJTlB1Sm5MSkhEbnloRUhRbllXcWpFdzVMcWUxNS1JRWxyNUNlMmNVcE5wcFI4YzAtNUY1UmpnMkYxcEVZeVozS0wzTXB4eFBhcU5TeWNLUXVUbWFXMm1INTg4UnJ0ZTQ?oc=5","date":"2025-07-31","type":"regulatory","source":"ir.lenz-tx.com","summary":"LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia - ir.lenz-tx.com","headline":"LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia - ir.lenz","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQTkU4cmYxTVpsdlEyOThOR1BUOGU4MGNjc2pjSU43NXU3VVcyZlFhZmRwQVVPTnp4ejBDRXFnOEtvT3c1T3A1TW5GQ0t6MjhTT05GTmpsaW04dDdPZEdpWW04UEROZUxkckRJQVAteTJ1RWxLS2s1ekJSYV9fWk5oSFB3ckpBM05CUFVHYVFnZ0U3Vi1pZnE2emh5Umw2SG5ma2Jfa1ozZDRteGc4T0RrTkJSc2RFVVpOUHdKenVDVUc5YWpJQV9r?oc=5","date":"2025-06-16","type":"pipeline","source":"PR Newswire","summary":"Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer - PR Newswire","headline":"Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQbUpleWgwOFBwbnlKX3lJTXB1ZWtFN2Y4WDZZWl9nU1RkZmtEQVl0bmxOZTRtQy1hbklBOG1NcmY1WGVRalhUQzQ4NTlvVUFlVXFveGlsTi11NzNMNFJrUTBuQTA5OXNIalA5ZmlWX1FKZXV4U1lndnNfRGxiSW44Tlhn?oc=5","date":"2025-06-13","type":"deal","source":"BUCKSCO.Today","summary":"Warrington’s Windtree Therapeutics Acquires Waste Management Company - BUCKSCO.Today","headline":"Warrington’s Windtree Therapeutics Acquires Waste Management Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNRUhOckE2ZU1fazZXU0ZJQkQtaS1VUkVLczBzZkU5dWRCdW1OSEo4VTQwcUxKWkR6cS1wYVYyTF9PWWo3RDExX3JoV2FpNXpVV0N5dmU1YlFpbk9pVzlUQzJ0cmMwdktaNmJhNFR1eS1pREdFZkpicTRCYmNXXzFaYmhLNEF5cTBNaWlnUmxkSWM2Z2VmSGZ3Y0NQNFo4OHJySkRyRlRIOUpnaFN3ZTd2WXpzOHRSc0w4cy1OYndwdE8xbWpnYVRWQkozZE13aUxpSDZqZzJvUkgzbHEzaDV3bHJYeG9WdUZubzF4MWh1N1cyVWRJZWViTV9saGY?oc=5","date":"2023-08-01","type":"pipeline","source":"Business Wire","summary":"Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets - Business Wire","headline":"Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}